The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Detection, quantification, and subtyping of adenoid cystic carcinoma (ACC) using methylation from liquid biopsies.
 
Felippe Lazar Neto
No Relationships to Disclose
 
Omnia Ahmed
No Relationships to Disclose
 
Camilla Hoff
Leadership - Oncologia D’Or (I)
Stock and Other Ownership Interests - Oncostar (I)
Honoraria - Bayer (I); Lilly (I)
Consulting or Advisory Role - Bayer (I); Lilly (I)
Research Funding - Exelixis (I); Lilly (I); Novartis (I)
 
Kimie Kondo
No Relationships to Disclose
 
Susana Pando
No Relationships to Disclose
 
Flavia Bonini
No Relationships to Disclose
 
Marcos Estecio
No Relationships to Disclose
 
Yoshitsugu Mitani
No Relationships to Disclose
 
Adel El-Naggar
No Relationships to Disclose
 
Daniel McGrail
No Relationships to Disclose
 
Renata Ferrarotto
Consulting or Advisory Role - Answers in CME; Bicara Therapeutics; Coherus Biosciences; Eisai; Johnson & Johnson/Janssen; Labcorp Drug Development; Pyxis; Raptor Pharmaceuticals; Regeneron; Rgenta
Research Funding - Avacta Life Sciences (Inst); Bicara Therapeutics (Inst); Gilead Sciences (Inst); ISA Pharmaceuticals (Inst); Merck Serono (Inst); Pfizer/EMD Serono (Inst); Remix Therapeutics (Inst); Rgenta (Inst); Seagen (Inst); Viracta Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Royalties on UpToDate chapter on olfactory neuroblastoma, ~ 300 dollars per year
Travel, Accommodations, Expenses - Bicara Therapeutics
 
Simon Heeke
Employment - Marker Therapeutics (I)
Honoraria - Qiagen
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - AstraZeneca; Guardant Health; Roche Molecular Diagnostics; Thermo Fisher Scientific
Research Funding - Bristol-Myers Squibb; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - Patent on the Treatment of Lung Cancer
Travel, Accommodations, Expenses - Roche